Herpes Infections Recently Cost $35 Billion Globally
By Lori Solomon HealthDay Reporter
THURSDAY, July 18, 2024 -- Herpes simplex virus (HSV)-2 and HSV-1 infections and their consequences cost $35 billion globally in 2016, according to a study published online July 2 in BMC Global and Public Health.
Nathorn Chaiyakunapruk, Pharm.D., Ph.D., from the University of Utah in Salt Lake City, and colleagues estimated the global economic impact of genital HSV-2 and HSV-1 infections. Disease burden was based on previously published global disease burden studies in 2016 for 194 countries, while estimates of health care resource utilization were sourced from a literature review and online interviews with 20 experts from all six World Health Organization regions.
The researchers found that genital HSV-2 ($31.2 billion) and HSV-1 ($4.0 billion) infections and their consequences were costly globally. The greatest economic burden emanated from the combined Americas and Western Pacific regions, which accounted for almost two-thirds of the global burden ($20.8 billion). A large proportion of the economic burden was borne by high- and upper middle-income countries (76.6 percent or $27.0 billion). HSV-2 recurrence drove costs.
"HSV prevention interventions have the potential to avert a large economic burden in addition to disease burden; thus, efforts to accelerate HSV vaccine development are crucial," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Many Teen Girls Seeking Care in the ED at High Risk for Pregnancy
WEDNESDAY, July 3, 2024 -- Sexually active adolescents seeking care in the emergency department have a high risk for pregnancy, and the emergency department may provide a feasible...
Only Half of Adults Believe They Should Disclose Sexually Transmitted Infection Status
FRIDAY, June 7, 2024 -- Only half of individuals disclose or believe they should disclose having a sexually transmitted infection (STI) prior to sexual intercourse, according to a...
CDC Recommends Doxycycline PEP for Gay Men, Transgender Women
WEDNESDAY, June 5, 2024 -- In clinical guidelines issued by the U.S. Centers for Disease Control and Prevention and published June 4 in the agency's Morbidity and Mortality Weekly...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.